In Phase III clinical trial data released last year, people on the highest dose of orforglipron lost, on average, 10% of their baseline body weight, compared to the 2.5% average weight loss seen in people taking a placebo
Cardiac Resynchronization Therapy with a Defibrillator (CRTd) in Failing Heart Patients with Type 2 Diabetes Mellitus and Treated by Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RA) Therapy vs
Grapefruit: Another citrus fruit that contains glutathione, grapefruit offers a tangy taste and numerous health benefits
What began as a promise of accessible care has morphed into a new digital frontier - one that raises a central question: Is the GLP-1 telehealth boom an innovation in patient empowerment, or the next great privacy nightmare
Not only that, the maximum safe discharge rate is a moving target that will fluctuate depending on several factors including pack temperature, age and internal resistance (more on this in a bit)
